Johnson & Johnson COVID-19 Vaccine Effective, Even Against Variants: Trial

A pharmacist volunteer prepares doses of the Johnson and Johnson COVID-19 vaccine during a pop-up clinic in Detroit, Mich., on April 12, 2021. Matthew Hatcher/Getty Images

Johnson & Johnson’s COVID-19 vaccine helps protect against moderate to severe illness, newly published clinical trial results show.

The jab was 67 percent effective in protecting against moderate to severe COVID-19, the disease caused by the CCP (Chinese Communist Party) virus, at 14 days after vaccination, according to research published in the New England Journal of Medicine.